Enforcement record
Voluntary Recall disclosure naming デンカ株式会社
This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.
Action type
Voluntary Recall
Law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
Authority
Ministry of Health, Labour and Welfare
Action date
8 November 2021
Current page: Enforcement record
This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.
Source verification
Public-source and preservation status
- Publishing authority
- Ministry of Health, Labour and Welfare
- Official source URL
- Recorded by RegBase
- Entity match
- Not confirmed; shown under the published name
- Kiroku preservation
- Completed archive verified
- Captured: Jul 12, 2026, 04:21 PM JST
“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.
Open the official source links in the section below to review the original disclosure.
Action summary
- Company
- デンカ株式会社Japanese onlyOriginal: デンカ株式会社
- Governing law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices医薬品医療機器等法
- Action type
- Voluntary Recall自主回収
- Action date
- 8 November 2021
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
- Industry context
- 医薬品・医療機器
Violation
Regarding the antigen rapid test kits, under the distribution project based on the Ministry of Health, Labour and Welfare's notice titled 'Distribution of antigen rapid test kits to medical institutions, elderly care facilities, etc.' dated June 9, 2021, a total of 1,201,300 units have been distributed out of the 1,300,000 units mentioned above. For the distributed antigen rapid test kits, the Ministry of Health, Labour and Welfare and others have sent distribution destination lists to Denka Corporation, and under Denka's responsibility, including cost burden, the exchange of the new antigen rapid test kits is planned to be carried out.
Show original Japanese text
抗原簡易キットについては、「医療機関・高齢者施設等への抗原簡易キット配布事業について」(令和3年6月9日付厚生労働省新型コロナウイルス感染症対策推進本部事務連絡)に基づく配布事業において、上記1,300,000個のうち1,201,300個が配布されております。配布済みの抗原簡易キットについては、厚生労働省等からデンカ株式会社に対し配布先リストの送付等を行い、費用負担も含めデンカ株式会社の責任の下で新しい抗原簡易キットの交換が行われる予定です。
Compliance context
Context neededThis is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.
Japanese regulatory disclosure under Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices.
Review the original Japanese source and determine relevance to your counterparty-risk workflow.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Open original sources and verification detailsOfficial URL, direct PDF, and Kiroku archive
- Extracted at
- 2026-04-25T00:20:41.156+00:00
- Evidence checked
- 2026-04-25T00:20:41.156+00:00
- Archive captured
- 2026-07-12T07:21:36.06795+00:00
Show audit JSON
{
"record": {
"id": "e30cfd89-3c25-47cb-8453-bfafe7a20778",
"url": "https://regbase.jp/en/enforcement/other-denka-20211108",
"company_name_original": "デンカ株式会社",
"company_name_registry": null,
"corporate_number": null,
"law": {
"ja": "医薬品医療機器等法",
"en": "Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices"
},
"action_type": {
"ja": "自主回収",
"en": "Voluntary Recall"
},
"authority": {
"ja": "厚生労働省",
"en": "Ministry of Health, Labour and Welfare"
}
},
"entity_match": {
"status": "unresolved",
"confidence": 85,
"method": "nta_strict_name_nationally_unique",
"method_label": "nta_strict_name_nationally_unique",
"notes": "NTA full-download lookup found a nationally unique exact registered-name candidate (デンカ株式会社). No Corporate Number was present in the disclosure, so this remains a likely match."
},
"review": {
"status": "unreviewed",
"label": "Machine extracted"
},
"compliance_context": {
"severity": "Context needed",
"actionMeaning": "This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.",
"practicalNote": "Review the original Japanese source and determine relevance to your counterparty-risk workflow.",
"lawContext": "Japanese regulatory disclosure under Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices."
},
"evidence": {
"recordUrl": "https://regbase.jp/en/enforcement/other-denka-20211108",
"officialSourceUrl": "https://www.mhlw.go.jp/stf/newpage_22115.html",
"officialDocumentUrl": null,
"archiveUrl": "https://kiroku.today/a/dedeb0cbf3hgrjap",
"archivedSourceUrl": "https://www.mhlw.go.jp/stf/newpage_22115.html",
"archiveCapturedAt": "2026-07-12T07:21:36.06795+00:00",
"extractedAt": "2026-04-25T00:20:41.156+00:00",
"translatedAt": "2026-05-01T07:09:02.249+00:00",
"evidenceCheckedAt": "2026-04-25T00:20:41.156+00:00",
"generatedAt": "2026-09-28T00:57:37.274Z"
},
"limitations": [
"RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
"English summaries are provided for reference. The original Japanese source is authoritative.",
"Possible or unresolved entity matches should be manually verified before use in a decision."
]
}The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.